Systemic Hormonal Contraceptive Use and Rhinitis Among Adult Women: An All of Us Database Analysis
Open Access
- 21 March 2025
- journal article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (2) , e70123
Abstract
Objectives: The role of sex hormones in the pathogenesis of allergic and inflammatory conditions such as rhinitis has been receiving increased attention, with evidence supporting an inflammation‐modulating role of estrogen and progesterone in the nasal mucosa. However, the specific influence of hormonal contraceptives in rhinitis has been sparsely studied. As such, we sought to investigate the association of systemic hormonal contraceptives with both allergic (AR) and nonallergic rhinitis (NAR) using a national data set of adults in the United States.Methods: This study was conducted using data from 46,205 female participants aged 20–40 in the All of Us Research Program. Rhinitis diagnoses, systemic hormonal contraceptive use, and covariate data were extracted for all participants. These variables were included in multivariable logistic regression models assessing the association of any systemic hormonal contraceptive use with rhinitis, both AR and NAR. Separate models were conducted to examine the association of progestin‐only contraceptives (POCs) and estrogen‐containing contraceptives (ECCs) on the odds of rhinitis. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated.Results: Systemic hormonal contraceptives were associated with AR (OR: 1.32; 95% CI: 1.20–1.44) but not NAR (OR: 1.20; 95% CI: 0.90–1.56) after controlling for covariates. When analyzing POCs and ECCs separately, both were associated with AR compared to those not taking any systemic hormonal contraceptives (OR: 1.29; 95% CI: 1.12–1.48 for POC, OR: 1.35; 95% CI: 1.21–1.51 for ECC) but were not significantly associated with NAR (OR: 1.04; 95% CI: 0.66–1.57 for POC, OR: 1.33; 95% CI: 0.95–1.81 for ECC).Conclusion: Systemic hormonal contraceptive use was independently associated with AR, with no significant difference between POCs and ECCs, while not being associated with NAR. Our findings may support a hormonal role in the pathogenesis of AR, but further research is needed to establish causation and understand the underlying mechanisms linking systemic hormonal contraceptive use to AR.Level of Evidence: 3.Keywords
Funding Information
- National Institutes of Health (K12AR084225)
This publication has 22 references indexed in Scilit:
- International consensus statement on allergy and rhinology: Allergic rhinitis – 2023International Forum of Allergy & Rhinology, 2023
- The “All of Us” Research ProgramNew England Journal of Medicine, 2019
- Hormones, sex, and asthmaAnnals of Allergy, Asthma & Immunology, 2018
- Endogenous and exogenous sex steroid hormones in asthma and allergy in females: A systematic review and meta-analysisJournal of Allergy and Clinical Immunology, 2018
- Menopausal hormone therapy may increase non-allergic rhinitis among postmenopausal women: Results from the Korea National Health and Nutrition Examination Survey (2010–2012)Maturitas, 2017
- Association of Estrogen-Related Traits with Allergic Rhinitis2017
- Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthmaJournal of Allergy and Clinical Immunology, 2015
- Evaluation of estrogenic receptors in the nasal mucosa of women taking oral contraceptivesContraception, 2011
- Expression and localization of steroid receptors in human nasal mucosaActa Oto-Laryngologica, 2004
- Association between asthma and rhinitis according to atopic sensitization in a population-based studyJournal of Allergy and Clinical Immunology, 2004